Indian pharmaceutical companies faces challenges at home and abroad2 min read . Updated: 28 Feb 2020, 12:05 AM IST
- All in all, it seems like pharma stocks may continue to undershoot the broader market for quite some time
- The Indian pharmaceutical market, which has been hedging against lack of growth in the US, clocked slower growth last month
It’s not going to be an easy recovery for the pharma sector. The home market has started to slacken, while the coronavirus outbreak has raised concerns of higher input costs. The Nifty Pharma index is down about 12% in 2019, compared with the Nifty 500’s gain of about 6.8%.
Get the best recommendations on Stocks, Mutual Funds and more based on your Risk profile!Let’s get started
Login to enjoy exclusive benefits!
- Unlocked premium articles
- Personalized news
- Market Watchlist
- Insightful Newsletters & more